Trk Fusion-positive Solid Tumors
📧 Sign up to get email alerts when something new happens for Trk Fusion-positive Solid Tumors.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-04-09FDA Approved: VITRAKVI — Supplemental Application (Loxo Oncology, Inc.)
FDA approved a supplemental application for VITRAKVI (larotrectinib) expanding its indication to TRK fusion-positive solid tumors in adults …